October Pharma S.A.E (EGX:OCPH)

Market Cap	1.23B
Revenue (ttm)	1.23B
Net Income (ttm)	151.84M
Shares Out	12.00M
EPS (ttm)	10.94
PE Ratio	9.37
Forward PE	n/a
Dividend	2.50 (2.44%)
Ex-Dividend Date	n/a

Volume	1,137
Average Volume	3,536
Open	102.49
Previous Close	102.49
Day's Range	101.27 - 104.00
52-Week Range	83.02 - 166.99
Beta	0.10
RSI	44.83
Earnings Date	May 27, 2025

About October Pharma S.A.E

October Pharma S.A.E manufactures and sells pharmaceutical products in Egypt. The company provides its products in solid forms, such as tablets, capsules, and powders; liquid forms comprising syrups, drops, solutions, and sprays; creams and suppositories; soft gelatin capsules; and ampoules and vials. October Pharma S.A.E was founded in 1987 is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Country: Egypt
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: OCPH

Financial Performance

In 2024, October Pharma S.A.E's revenue was 1.23 billion, an increase of 21.39% compared to the previous year's 1.01 billion. Earnings were 151.84 million, an increase of 0.96%.